About HEMATO

HEMATO is Effective, Economical, Efficient, Essential and for Everyone.

HEMATO is the most Comprehensive Stem Cells Platform of Transcell Oncologics Pvt Ltd with specific focus on use of Adult Stem Cells for PREDICTIVE Genetic Analysis, TRUSTED CRYOstorage, ADVANCED FORMULATIONS for Stem Cell Transplantation and Therapy including HSCT for the Healthy, Unwell requiring Treatments, even those Cured but Immunity compromised, Strong and Weak, Young and Old, Kids and Adults, Men and Women and practically EVERYONE.

HEMATO provides the most advanced clinical processing capabilities from its GMP facilities in Hyderabad. It has state-of-the-art equipment managed by highly qualified resources consisting of PhDs with a large number of published papers and citations among their peer community.

HEMATO is engaging with over 1500 Hematologists, Transfusion Medicine Specialists, Oncologists, Genetics specialists, Regenerative Medicine specialists, Nutritionists, Wellness & Health experts across the country.

HEMATO is building its network of 100+ Hospital engagements with Genetics and use of Adult Stem Cells as a common connect with medical domains beyond Oncology/Hematology such as Cardiology, Neurology, Nephrology, Endocrinology, Orthopaedics, Gynaecology, Immunology, Rheumatology, Gastroenterology, Anatomy, Geriatrics, Dentistry, Internal medicine and more, for both, Pediatric and Adult requirements.

HEMATO currently offers

  • HEMATO PREGEN – PREDICTIVE Genetic Health Signature Analysis and Report based on 20,000+ genes, harvested from Primary and Progenitor Cells, subjected to “Omics” (Transcriptomics and Genomics) with NGS/WES (Next Generation/Whole Exome Sequencing) and analysed using GenePoweRx Bioinformatics Engine with AI & ML, approved by Memorial Sloan Kettering Cancer Center, USA to predict Genetic Anomalies which can cause up to 90& of the diseases, and with 99% Accuracy. It also includes extensive Nutrigenomics assessment. HEMATO PREGEN
  • HEMATOCRYO – TRUSTED CRYOstorage of Healthy Stem Cells from Peripheral Blood or Bone Marrow or Umbilical Cord for few days, weeks, months and even years (up to 10 years) using Controlled Rate Freezing process with Advanced Clinical Processes customized as per cell type and condition to CRYOstore at -196 o C under Vapour Liquid Nitrogen (LN 2 ) environment. HEMATOCRYO
  • HEMATO HSCT – Advanced Formulations with Enriched or Depleted Cell Options for Hematopoietic Stem Cell Transplantation including CD19-, CD34+, CD45-, TcRαβ and options for NK Cells and beyond. HEMATO HSCT
  • HEMATO MESEN – Mesenchymal Stromal/Stem Cells for GVHD (post Allogeneic HSCT procedure and as may be required by any Practitioner /Hospital for their patients. HEMATO MESEN
  • HEMATO Supporting Services – Apheresis, HLA Typing, Medical Logistics and other related services for any of the aforementioned HEMATO offerings.

Transcell Oncologics is also focused on Advanced Stem Cell Technologies prowess into Cancer Clinical Reality (www.transcellonco.sciences) and Human Surrogate cell/tissue in vitro systems for next generation preclinical & clinical testing (www.transtoxbio.com).